基本资料 投资组合 财务数据 基金公告
创金合信全球医药生物股票发起(QDII)C(018156) |
净值：
1.7526
|
日增长率：
-2.84%
|
累计净值：1.7526 | 2025-12-29 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| CDTX | Cidara Therapeutics Inc | 3,430.00 | 2,333,849.79 | 5.93 |
| ANAB | AnaptysBio Inc | 10,000.00 | 2,175,704.10 | 5.53 |
| TSHA | Taysha Gene Therapies Inc | 82,600.00 | 1,919,209.76 | 4.88 |
| GRAL | GRAIL Inc | 4,200.00 | 1,764,622.50 | 4.49 |
| URGN | 乌龙制药 | 12,000.00 | 1,701,056.70 | 4.32 |
| XNCR | Xencor Inc | 20,200.00 | 1,683,619.80 | 4.28 |
| OLMA | Olema Pharmaceuticals Inc | 23,057.00 | 1,603,910.52 | 4.08 |
| NKTR | 内克塔治疗 | 3,710.00 | 1,499,963.94 | 3.81 |
| ZYME | Zymeworks Inc | 11,500.00 | 1,395,662.31 | 3.55 |
| ERAS | Erasca Inc | 86,918.00 | 1,346,358.95 | 3.42 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2025-09-30 | 85.79 | - | 13.08 | 39,332,950.53 |
| 2025-06-30 | 84.55 | - | 9.62 | 13,846,914.86 |
| 2025-03-31 | 84.53 | - | 18.85 | 12,369,113.13 |
| 2024-12-31 | 81.01 | - | 15.98 | 12,618,309.46 |
| 2024-09-30 | 86.15 | - | 19.92 | 12,529,208.02 |
微信公众号
证券之星APP
